Genovis AB (publ.) (STO:GENO)

Sweden · Delayed Price · Currency is SEK

16.90

-0.40 (-2.31%)

Mar 2, 2026, 5:24 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology (Startups)	129.65M	131.32M	159.07M	103.56M	93.68M
Biotechnology (Startups) Growth	-1.27%	-17.44%	53.60%	10.55%	53.49%
Total	129.65M	131.32M	159.07M	103.56M	93.68M
Total Growth	-1.27%	-17.44%	53.60%	10.55%	53.49%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Sweden	3.49M	795.00K	631.00K	636.73K
Sweden Growth	338.99%	25.99%	-0.90%	23.69%
Rest of World	126.87M	157.44M	101.76M	92.38M
Rest of World Growth	-19.42%	54.72%	10.15%	52.66%
Total	130.36M	158.23M	102.39M	93.02M
Total Growth	-17.62%	54.54%	10.07%	52.41%

Source: S&P Global Market Intelligence.